Posted by Michael Wonder on 02 Jan 2024
Expanded PBS listings make vital treatments more affordable
2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic syndrome, will have access to cheaper medicines under the PBS.
Olaparib (Lynparza) will be expanded for eligible Australian women with newly diagnosed advanced ovarian cancer.
